Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo
We aim to study the impact of perioperative IV lidocaine on postoperative pain control in patients undergoing paraesophageal hernia repair. This is in the context of an established ERAS protocol. We wish to study the effect of IV Lidocaine on postoperative short and long-term outcomes, including patients' length of stay postoperative mortality, morbidity, and quality of life. We will compare this to our standard pain management.
• Patients aged 18+ years of age
• American Association of Anesthesiologists (ASA) scores of I-III
• Undergoing elective laparoscopic paraesophageal hernia repair including robotic assisted laparoscopic cases.
• All paraesophageal hernia patients seen in clinic who meet inclusion criteria will be given the option to enroll.
• Cases converted to open laparotomy or hand-assisted laparoscopy will be included for intention to treat analysis.
• Patients who have complications of Clavien-Dindo class 3 or greater will be included in calculations of complication rates. However, they will not be included in calculations of postoperative morphine equivalents, as repeat intervention will confound the normal course of postoperative pain control.